Acadian Asset Management
HURA

Acadian Asset Management’s TuHURA Biosciences HURA Stock Holding History

Acadian Asset Management’s Portfolio HURA Stock Details HURA Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q1 		$0 Hold
20
– – ﹤0.01% 2288
2025
Q4 		$0 Buy
20
+9
+82% +$17 ﹤0.01% 2152
2025
Q3 		$0 Hold
11
– – ﹤0.01% 2044
2025
Q2 		$0 Hold
11
– – ﹤0.01% 1870
2025
Q1 		$0 Buy
11
+1
+10% +$4 ﹤0.01% 1842
2024
Q4 		$0 Hold
10
– – ﹤0.01% 2244
2024
Q3 		$0 Hold
10
– – ﹤0.01% 2388
2024
Q2 		$0 Hold
10
– – ﹤0.01% 1922
2024
Q1 		$0 Sell
10
-3,641
-100% -$14.6K ﹤0.01% 1823
2023
Q4 		$21K Buy
3,651
+3,466
+1,874% +$179K ﹤0.01% 1586
2023
Q3 		$25K Hold
185
– – ﹤0.01% 1512
2023
Q2 		$25K Hold
185
– – ﹤0.01% 1618
2023
Q1 		$22K Hold
185
– – ﹤0.01% 1644
2022
Q4 		$44K Sell
185
-127
-41% -$28.2K ﹤0.01% 1594
2022
Q3 		$57K Buy
312
+194
+164% +$62K ﹤0.01% 1479
2022
Q2 		$58K Buy
+118
New +$51.4K ﹤0.01% 1471

Other funds holding HURA

BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
VCM
Vanguard Capital Management Malvern, Pennsylvania $4.04T AUM
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return
AQR Capital Management
AQR Capital Management Greenwich, Connecticut $218B AUM 29.41% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
Northern Trust
Northern Trust Chicago, Illinois $757B AUM 28.64% 1-Year Est. Return
VFT
Vanguard Fiduciary Trust Malvern, Pennsylvania $396B AUM
VPM
Vanguard Portfolio Management Malvern, Pennsylvania $1.91T AUM
Bank of New York Mellon
Bank of New York Mellon New York $544B AUM 28.31% 1-Year Est. Return
AWM
Apollon Wealth Management Mount Pleasant, South Carolina $6.15B AUM 22.62% 1-Year Est. Return

Acadian Asset Management's HURA Position: Q1 2026 in Review

Acadian Asset Management held its TuHURA Biosciences (HURA) position steady in Q1 2026 at 20 shares worth $0. The position accounts for ﹤0.01% of the portfolio, ranked #2288.

Acadian Asset Management first reported a position in HURA in Q2 2022 and has held it in 16 quarters since. The position peaked at $58K in Q2 2022. 89 funds tracked by Wall St. Rank hold HURA as of Q1 2026.

  • Acadian Asset Management held 20 shares of TuHURA Biosciences worth $0 as of Q1 2026.
  • Acadian Asset Management left its TuHURA Biosciences share count unchanged in Q1 2026.
  • TuHURA Biosciences made up ﹤0.01% of Acadian Asset Management's portfolio in Q1 2026, its #2288 holding.
  • Acadian Asset Management first reported a position in TuHURA Biosciences in Q2 2022 and has held it in 16 quarters since.
  • Acadian Asset Management's TuHURA Biosciences position peaked at $58K in Q2 2022.
  • 89 funds tracked by Wall St. Rank held TuHURA Biosciences as of Q1 2026.

Based on Acadian Asset Management's 13F filing for Q1 2026, filed 13 May 2026.